Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 200 Total
FCEL - Fuelcell Energy Inc - Stock Price Chart
TickerFCEL [NASD, RUT]
CompanyFuelcell Energy Inc
CountryUSA
IndustryElectrical Equipment & Parts
Market Cap420.60MEPS (ttm)-0.26
P/E-EPS this Y-5.40%
Forward P/E-EPS next Y6.70%
PEG-EPS past 5Y50.65%
P/S4.08EPS next 5Y15.00%
P/B0.63EPS Q/Q4.80%
Dividend-Sales Q/Q-54.98%
Insider Own0.34%Inst Own43.95%
Insider Trans0.00%Inst Trans4.18%
Short Float19.71%EarningsMar 07/b
Analyst Recom3.10Target Price1.47
Avg Volume12.06M52W Range0.98 - 2.94
FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Feasel MarkEVP & Ch. Commercial OfficerMar 25 '24Option Exercise0.0083,4930164,343Mar 27 04:34 PM
Dolger JoshuaGeneral Counsel & Corp SecDec 11 '23Option Exercise0.004,710021,311Dec 13 04:44 PM
Few JasonCEODec 11 '23Option Exercise0.0020,8330841,954Dec 13 04:47 PM
Bishop Michael S.EVP, TREASURER & CFODec 11 '23Option Exercise0.006,5220175,579Dec 13 04:48 PM
Feasel MarkEVP & Ch. Commercial OfficerDec 11 '23Option Exercise0.006,522083,310Dec 13 04:42 PM
AVXL - Anavex Life Sciences Corporation - Stock Price Chart
TickerAVXL [NASD, RUT]
CompanyAnavex Life Sciences Corporation
CountryUSA
IndustryBiotechnology
Market Cap312.02MEPS (ttm)-0.54
P/E-EPS this Y20.00%
Forward P/E-EPS next Y-33.33%
PEG-EPS past 5Y-9.03%
P/S-EPS next 5Y-
P/B2.30EPS Q/Q36.90%
Dividend-Sales Q/Q-
Insider Own3.16%Inst Own31.68%
Insider Trans-2.75%Inst Trans-2.04%
Short Float27.81%EarningsFeb 07/b
Analyst Recom1.00Target Price32.50
Avg Volume1.25M52W Range4.02 - 10.45
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MISSLING CHRISTOPHER UPresident and CEOMar 28 '24Option Exercise1.3273,38096,8621,323,590Apr 01 06:00 PM
MISSLING CHRISTOPHER UPresident and CEOMar 28 '24Sale5.1173,380374,9721,250,210Apr 01 06:00 PM
MISSLING CHRISTOPHER UPresident and CEOJun 29 '23Option Exercise1.60232,000371,2001,250,210Jun 30 08:00 PM
MISSLING CHRISTOPHER UPresident and CEOJun 28 '23Option Exercise1.60268,000428,8001,286,210Jun 30 08:00 PM
MISSLING CHRISTOPHER UPresident and CEOJun 28 '23Sale7.98268,0002,139,3101,018,210Jun 30 08:00 PM
GHG - GreenTree Hospitality Group Ltd ADR - Stock Price Chart
TickerGHG [NYSE]
CompanyGreenTree Hospitality Group Ltd ADR
CountryChina
IndustryLodging
Market Cap188.21MEPS (ttm)-
P/E-EPS this Y105.82%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-8.29%
P/S-EPS next 5Y3.63%
P/B-EPS Q/Q-71.76%
Dividend8.06%Sales Q/Q7.28%
Insider Own-Inst Own12.45%
Insider Trans-Inst Trans-0.69%
Short Float-EarningsMar 26/b
Analyst Recom3.00Target Price4.45
Avg Volume5.10K52W Range2.90 - 6.78
GreenTree Hospitality Group Ltd. is a holding company engaged in the hospitality business. It specializes in the franchise, management, and operation of hotels in China through the GreenTree Inns brand. The company was founded by Alex S. Xu on October 18, 2017 and is headquartered in Shanghai, China.
AONC - American Oncology Network Inc - Stock Price Chart
TickerAONC [NASD]
CompanyAmerican Oncology Network Inc
CountryUSA
IndustryMedical Care Facilities
Market Cap47.96MEPS (ttm)-1.53
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.07EPS next 5Y-
P/B-EPS Q/Q-1928.47%
Dividend-Sales Q/Q-
Insider Own73.62%Inst Own1.62%
Insider Trans0.00%Inst Trans10.27%
Short Float0.91%EarningsMar 28/b
Analyst Recom-Target Price-
Avg Volume9.28K52W Range4.78 - 39.60
American Oncology Network, Inc. engages in the provision of community-based oncology management. The company was founded in 2018 and is headquartered in Fort Myers, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Saba Capital Management, L.P.10% OwnerSep 25 '23Sale10.50205,5122,157,8760Sep 25 05:59 PM
TVGN - Tevogen Bio Holdings Inc. - Stock Price Chart
TickerTVGN [NASD]
CompanyTevogen Bio Holdings Inc.
CountryUSA
IndustryBiotechnology
Market Cap33.54MEPS (ttm)0.07
P/E30.81EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B3.41EPS Q/Q-152.38%
Dividend-Sales Q/Q-
Insider Own6.10%Inst Own11.03%
Insider Trans0.00%Inst Trans0.47%
Short Float0.08%Earnings-
Analyst Recom-Target Price-
Avg Volume355.04K52W Range2.22 - 21.09
Apr-11-24 08:05AM Tevogen Bio's Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target Cancers (GlobeNewswire)
Apr-03-24 08:05AM Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development (GlobeNewswire) -11.19%
Mar-28-24 08:05AM Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price (GlobeNewswire) +8.05%
Mar-27-24 09:20AM Tevogen Bio Announces Series A-1 Preferred Stock Investment (GlobeNewswire) -10.65%
Mar-20-24 07:00AM Tevogen Bio Reports Its Investigational SARS-CoV-2 Specific T Cell Therapy, TVGN-489, Retains Activity Against the Dominant JN.1 Variant (Business Wire)
Mar-05-24 08:00AM Tevogen Bio Holdings Congratulates its Board Member and Esteemed Global Safety Management Expert, Victor Sordillo, on His appointment as Managing Director of Risk Advisory Services at Verita (Business Wire)
Feb-27-24 04:39PM Mittul Mehta, Head of Tevogen's Artificial Intelligence Initiative Tevogen.ai, Emphasizes Importance of Proactive Talent Development for Biopharmaceutical Sector to Allow Rapid Adoption of AI (Business Wire)
Feb-21-24 07:00AM Cell Therapy Company Tevogen Bio Holdings Inc. Prepares to Launch Crucial Genetic Predisposition Study in Preparation to Investigate the Potential of TVGN 489 to Address Critical Unmet Need for Long COVID Treatment (Business Wire)
Feb-17-24 12:17AM Cell Therapy Company Tevogen Bio Holdings Inc. (Nasdaq: TVGN) Rings Opening Bell at Nasdaq Exchange on February 15th, 2024, Begins Public Trading on the Open Market (Business Wire)
Feb-15-24 09:25AM Tevogen Bio Announces $8 Million Equity Investment (Business Wire) +121.73%
Tevogen Bio Holdings, Inc. is a clinical-stage specialty immunotherapy company. It develops off-the-shelf therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company was founded on February 14, 2024 and is headquartered in Warren, NJ.
ENZ - Enzo Biochem, Inc. - Stock Price Chart
TickerENZ [NYSE]
CompanyEnzo Biochem, Inc.
CountryUSA
IndustryDiagnostics & Research
Market Cap57.89MEPS (ttm)-0.93
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-41.99%
P/S0.82EPS next 5Y-
P/B0.81EPS Q/Q72.24%
Dividend-Sales Q/Q-53.20%
Insider Own30.47%Inst Own32.03%
Insider Trans0.00%Inst Trans-2.82%
Short Float2.02%Earnings-
Analyst Recom1.00Target Price5.50
Avg Volume102.77K52W Range1.13 - 2.74
Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which engages in the manufacture, development and market of products and tools for clinical research, translational research, drug development and bioscience research. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in August 1976 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cannon KaraChief Executive OfficerFeb 21 '24Option Exercise0.0010,6400307,120Feb 27 07:22 PM
MGX - Metagenomi Inc. - Stock Price Chart
TickerMGX [NASD]
CompanyMetagenomi Inc.
CountryUSA
IndustryBiotechnology
Market Cap290.39MEPS (ttm)-
P/E-EPS this Y85.68%
Forward P/E-EPS next Y4.79%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own49.18%Inst Own0.00%
Insider Trans5.13%Inst Trans-
Short Float5.23%EarningsMar 28/b
Analyst Recom1.00Target Price21.20
Avg Volume227.73K52W Range8.10 - 12.74
Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit-ing toolbox, ther-a-peu-tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Novo Holdings A/S10% OwnerFeb 13 '24Buy15.00800,00012,000,0001,739,175Feb 15 08:38 PM
Novo Holdings A/S10% OwnerFeb 09 '24Buy10.25100,0001,025,000100,000Feb 15 08:38 PM
INTZ - Intrusion Inc - Stock Price Chart
TickerINTZ [NASD]
CompanyIntrusion Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap3.26MEPS (ttm)-12.01
P/E-EPS this Y76.49%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.58EPS next 5Y-
P/B-EPS Q/Q63.78%
Dividend-Sales Q/Q-5.40%
Insider Own28.47%Inst Own4.08%
Insider Trans314.56%Inst Trans-
Short Float2.11%EarningsMar 26/a
Analyst Recom3.00Target Price3.00
Avg Volume114.29K52W Range1.70 - 39.60
Intrusion, Inc. is a cybersecurity company, which offers customers access to its exclusive threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol addresses. Its solutions include INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. The company was founded by T. Joe Head and G. Ward Paxton in September 1983 and is headquartered in Plano, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LEVECCHIO ANTHONY JDirectorApr 04 '24Option Exercise2.918,33424,25220,611Apr 04 06:46 PM
Scott AnthonyChief Executive OfficerApr 02 '24Option Exercise2.9133,33497,00252,533Apr 04 06:54 PM
PINSON KIMBERLYChief Financial OfficerApr 02 '24Option Exercise2.913,3349,7025,076Apr 04 06:51 PM
Scott AnthonyChief Executive OfficerDec 31 '23Buy0.221,500330383,980Jan 24 03:43 PM
PINSON KIMBERLYChief Financial OfficerDec 31 '23Buy0.221,50033034,833Jan 24 03:42 PM
TACT - Transact Technologies Inc. - Stock Price Chart
TickerTACT [NASD]
CompanyTransact Technologies Inc.
CountryUSA
IndustryComputer Hardware
Market Cap46.41MEPS (ttm)0.47
P/E9.86EPS this Y-138.98%
Forward P/E33.29EPS next Y160.87%
PEG0.49EPS past 5Y-7.49%
P/S0.64EPS next 5Y20.00%
P/B1.18EPS Q/Q-123.66%
Dividend-Sales Q/Q-26.13%
Insider Own19.20%Inst Own57.80%
Insider Trans-6.26%Inst Trans0.30%
Short Float0.57%EarningsMar 12/a
Analyst Recom1.00Target Price9.50
Avg Volume19.34K52W Range4.78 - 9.44
TransAct Technologies, Inc. engages in the operation of a software-driven technology and printing solutions company. The company was founded in June 1996 and is headquartered in Hamden, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DILLON JOHNCEOMar 04 '24Option Exercise0.00677069,037Mar 04 04:24 PM
DEMARTINO STEVEN APresident, CFO, Treas. & Secr.Mar 04 '24Option Exercise0.00833098,772Mar 04 04:35 PM
Olinger HaydeeDirectorMar 04 '24Option Exercise0.001,100021,560Mar 04 06:11 PM
Friedman Randall SDirectorMar 04 '24Option Exercise0.001,10008,450Mar 04 06:14 PM
Hilario Emanuel P.N.DirectorMar 04 '24Option Exercise0.001,100016,100Mar 04 06:09 PM
AKAN - Akanda Corp - Stock Price Chart
TickerAKAN [NASD]
CompanyAkanda Corp
CountryUnited Kingdom
IndustryDrug Manufacturers - Specialty & Generic
Market Cap1.12MEPS (ttm)-4.08
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.28EPS next 5Y-
P/B0.02EPS Q/Q-62.56%
Dividend-Sales Q/Q1811.79%
Insider Own11.42%Inst Own0.50%
Insider Trans0.00%Inst Trans-92.54%
Short Float0.02%Earnings-
Analyst Recom-Target Price-
Avg Volume4.11M52W Range0.10 - 2.70
Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered New Romney, the United Kingdom.
1234567891020